Events

Recall of Device Recall LVarlock Cage/Trial Implant Holder

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by Kiscomedica S.A..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    76494
  • Event Risk Class
    Class 2
  • Event Number
    Z-1461-2017
  • Event Initiated Date
    2017-01-11
  • Event Date Posted
    2017-02-27
  • Event Status
    Terminated
  • Event Country
    United States
  • Event Source
    USFDA
  • Event Source URL
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=153360
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    Intervertebral fusion device with bone graft, lumbar - Product Code MAX
  • Reason
    Firm received a complaint of the tip holder breaking during use.
  • Action
    Manufacturer's Field Safety Corrective Action Report was submitted to ANSM (French Health Products Safety Agency) on January 11, 2017. The Field Safety Notice was sent to U.S. Consignee on January 18, 2017. The letter identified the affected product, problem and actions to be taken.

Device

Device Recall LVarlock Cage/Trial Implant Holder
  • Model / Serial
    Batch number: 15486
  • Product Classification
    Orthopedic Devices
  • Device Class
    2
  • Implanted device?
    Yes
  • Distribution
    Worldwide Distribution - US Nationwide in the states of MO and country of Switzerland.
  • Product Description
    L-Varlock Cage/Trial Implant Holder, Reference HD0060, Kisco International, France. || Product Usage: || The L-Varlock Lumbar Cage is indicated for intervertebral body fusion procedures in skeletally mature patients with degenerative disc disease (DDD) of the lumbar spine at one or two contiguous levels from L2-S1. DDD is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. These DDD patients may also have up to Grade I spondylolisthesis at the involved level(s). L-Varlock Lumbar implants are to be used with autogenous bone graft and implanted via an open posterior approach. L-Varlock Lumbar implant is to be used with supplemental fixation. Patients should have at least six (6) months of non-operative treatment prior to treatment with an intervertebral cage.
  • Manufacturer
    Kiscomedica S.A.

Manufacturer

Kiscomedica S.A.
  • Manufacturer Address
    Kiscomedica S.A., Parc Technologique - 2 Place, Berthe Morisot, Saint Priest France
  • Source
    USFDA